Skip to main content
. Author manuscript; available in PMC: 2015 May 15.
Published in final edited form as: J Immunol. 2014 Apr 18;192(10):4592–4600. doi: 10.4049/jimmunol.1302517

Table IV.

C1/x Recipients Receiving Transplants with Mismatch at HLA-C Benefit from Enhanced Protection with KIR-Better/Best Donors

A: Transplants with Mismatch at HLA Class I or Class I and Class II vs. Mismatch at HLA Class II
Donor KIR Group Includes Class I Mismatch Class II Mismatched Only
N RR P N RR P
LFS KIR-Neutral 310 1.00 53 1.00
KIR-Better/Best 131 0.69 (0.54–0.88) 0.0029 22 1.31 (0.57–3.02) 0.53
Relapse KIR-Neutral 323 1.00 59 1.00
KIR-Better/Best 134 0.62 (0.42–0.92) 0.019 22 1.45 (0.47–4.50) 0.52
B: HLA Class I Mismatch Transplants at HLA-C vs. HLA-A and/or HLA-B
Donor KIR Group HLA-C Mismatched HLA-A,B Mismatched
N RR P N RR P
LFS KIR-Neutral 185 1.00 125 1.00
KIR-Better/Best 83 0.57 (0.40–0.79) 0.001 48 0.97 (0.63–1.49) 0.89
Relapse KIR-Neutral 192 1.00 131 1.00
KIR-Better/Best 85 0.54 (0.33–0.88) 0.013 49 0.68 (0.32–1.45) 0.32